N/A
N=309
Home-based Kidney Care in Native Americans of New Mexico (HBKC) - Enhancement: COVID-19 Study
CKD
Bottom Line
View on ClinicalTrials.gov: NCT04520191 ↗Enrolled (actual)
309
Serious AEs
0.0%
Results posted
Mar 2025
Primary outcome: Primary: Number of Participants With Problems in Their Health Care Due to COVID-19 Related Isolation — 155 Participants
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Adult, Older Adult · 21+ yrs
- Sex
- All
- Sponsor
- University of New Mexico
- Primary completion
- Aug 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With Problems in Their Health Care Due to COVID-19 Related Isolation |
155 | — |
Summary
Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) OR COVID-19 related Addition: The aim of this addition activity is to track the impact of the COVID-19 epidemic on participants with diabetes and chronic kidney disease (CKD). Investigators have modified the original HBKC Study protocol to expand data currently collected from study participants to include data in the following domains linked to the COVID-19 epidemic:
symptoms of COVID-19 disease, access to healthcare, and impact on health related behaviors (such as medication adherence, physical activity, dietary behaviors, smoking, and alcohol use).
Eligibility Criteria
Inclusion Criteria
- Willingness to participate in the phone-based and or mail based survey.
Exclusion Criteria
- None
Data sourced from ClinicalTrials.gov (NCT04520191). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.